Pharmaceutical compositions and methods for using are provided for
restoring .beta.-cell mass and function in a mammal in need thereof. The
pharmaceutical compositions have a biological response modifier and a
.beta.-cell growth factor in admixture with a pharmaceutically acceptable
carrier, adjuvant or vehicle.